KIYATEC adds Oregon Health & Science University to study to predict response to cancer therapy prior to treatment
February 01, 2019
KIYATEC announces OHSU is enrolling newly diagnosed and relapsed ovarian cancer patients into the company’s 3-D PREDICT study, designed to predict response to cancer therapy prior to treatment.